definiens: and other cognate expressions shall be defined accordingly ) means a development plan agreed by the Collaboration and Development Committee in relation to a Product in the Field pursuant to clause 5.7(a ) means to do all or any of the following : distribute, purchase, store, warehouse, market, promote, sell, offer for sale, provide samples, import, export, otherwise contract with and/or manage Authorized Resellers . and ship, including the grant of any licences required for such purposes DuraSite Technology means the proprietary ophthalmic drug delivery formulation technology Controlled by Insite that contains a cross - linked polyacrylic acid polymer and that is currently known as and consists of polycarbophil, sodium chloride . EDT A and at least a single active pharmaceutical ingredient, as such technology is adapted by or for Insite in accordance with this Agreement as required for the Products -4 - CONFIDENTIAL TREATMENT REQUESTED BY INSITE VISION INCORPORATED DuraSite 2 Effective Date EMA Equivalent Products EXisting Insite Patents Exploit, Exploiting, andlor Exploitation FDA Field First Commercial Sale to obtain Regulatory Approval in the Field in the Territory ; provided that the shall not include ( a ) any next generation cross - linked polyacrylic acid polymer technology ( such as DuraSite 2 ) ; ( b ) any Insite Patented Improvements after the Payment Period ; ( c ) any Insite Non - Patented Improvements created after the fifth anniversary of the Effective Date, unless a licence is agreed by the Parties pursuant to the provisions of clause 7.18(c ) ; or ( d ) any technology related to information, data or Improvements resulting from an independen t study conducted by Insile under clause 7.10 ( except to the extent [COMPANY] acquires a righl to use such information, data and Improvements under clause 7.13 and, if applicable, clause 7.18 ) means the proprietary drug delivery formulation technology that contains ( a ) a cross - linked polyacrylic acid polymer ; and ( b ) Chitosan or another cationic polymer . which formulations are currently known as means the date of this Agreement means the European Medicines Agency, or any successor entity thereto means the versions of the Products ( to the extent not identical to them ), as adapted andlor developed andior used ( or intended for use ) outside the Territory by or on behalf of Insite or under licence from Insite to the extent the terms of such licence enable Insite to disclose its licensee 's versions of the Products ( or elements thereof ) to [COMPANY] without further payment provided that InMe shall use reasonable commerc ial efforts to obtain such enabling terms in its licence agreements with such licensees means the Patents set out in Appendix 0 and all Patents in the Territory ( and outside the Territory with respect to Patents covering the manufacture andlor Deve(opment ( other than clinical Development ) of Products ) that claim priority from any of them ; provided that, for the avoidance of doubt, shall not include the Pfizer Patents means Development, Distribution, andlor Manufacture means the United States Food and Drug Administration . or any successor entity thereto means the topical treatment of human ophthalmiC diseases, infections, inflammatory and other conditions of the human eye ; provided that, for the avoidance of doubt, shall not include any veterinary applications means, with regard to a specific Product in a country of the Territory